nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP3A7—Temsirolimus—kidney cancer	0.0827	0.101	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0827	0.101	CbGbCtD
Praziquantel—CYP3A5—Temsirolimus—kidney cancer	0.0621	0.0759	CbGbCtD
Praziquantel—CYP2D6—Temsirolimus—kidney cancer	0.0381	0.0466	CbGbCtD
Praziquantel—CYP3A4—Everolimus—kidney cancer	0.0358	0.0438	CbGbCtD
Praziquantel—CYP3A7—Paclitaxel—kidney cancer	0.0284	0.0347	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0284	0.0347	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0252	0.0309	CbGbCtD
Praziquantel—CYP3A7—Sorafenib—kidney cancer	0.0252	0.0309	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0245	0.03	CbGbCtD
Praziquantel—CYP3A7—Vincristine—kidney cancer	0.0245	0.03	CbGbCtD
Praziquantel—CYP1A2—Pazopanib—kidney cancer	0.0243	0.0297	CbGbCtD
Praziquantel—CYP3A4—Temsirolimus—kidney cancer	0.0242	0.0296	CbGbCtD
Praziquantel—CYP3A5—Erlotinib—kidney cancer	0.0233	0.0285	CbGbCtD
Praziquantel—CYP3A5—Paclitaxel—kidney cancer	0.0213	0.0261	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0204	0.025	CbGbCtD
Praziquantel—CYP3A7—Sunitinib—kidney cancer	0.0204	0.025	CbGbCtD
Praziquantel—CYP2D6—Pazopanib—kidney cancer	0.02	0.0245	CbGbCtD
Praziquantel—CYP3A5—Sorafenib—kidney cancer	0.0189	0.0231	CbGbCtD
Praziquantel—CYP3A5—Vincristine—kidney cancer	0.0184	0.0225	CbGbCtD
Praziquantel—CYP1A2—Erlotinib—kidney cancer	0.0173	0.0212	CbGbCtD
Praziquantel—CYP3A5—Sunitinib—kidney cancer	0.0153	0.0188	CbGbCtD
Praziquantel—CYP2C19—Sorafenib—kidney cancer	0.0153	0.0187	CbGbCtD
Praziquantel—CYP2D6—Erlotinib—kidney cancer	0.0143	0.0175	CbGbCtD
Praziquantel—CYP1A2—Sorafenib—kidney cancer	0.0141	0.0172	CbGbCtD
Praziquantel—CYP3A4—Pazopanib—kidney cancer	0.0127	0.0156	CbGbCtD
Praziquantel—CYP2D6—Sorafenib—kidney cancer	0.0116	0.0142	CbGbCtD
Praziquantel—CYP2D6—Vinblastine—kidney cancer	0.0115	0.014	CbGbCtD
Praziquantel—CYP3A4—Erlotinib—kidney cancer	0.00907	0.0111	CbGbCtD
Praziquantel—CYP3A4—Paclitaxel—kidney cancer	0.0083	0.0102	CbGbCtD
Praziquantel—CYP3A4—Sorafenib—kidney cancer	0.00738	0.00903	CbGbCtD
Praziquantel—CYP3A4—Vinblastine—kidney cancer	0.00728	0.00891	CbGbCtD
Praziquantel—CYP3A4—Vincristine—kidney cancer	0.00716	0.00876	CbGbCtD
Praziquantel—CYP2D6—Doxorubicin—kidney cancer	0.00704	0.00861	CbGbCtD
Praziquantel—CYP3A4—Sunitinib—kidney cancer	0.00598	0.00731	CbGbCtD
Praziquantel—CYP3A4—Doxorubicin—kidney cancer	0.00447	0.00548	CbGbCtD
Praziquantel—CYP2C19—urine—kidney cancer	0.00191	0.183	CbGeAlD
Praziquantel—CYP1A2—urine—kidney cancer	0.00156	0.149	CbGeAlD
Praziquantel—CYP3A4—urine—kidney cancer	0.00113	0.108	CbGeAlD
Praziquantel—CYP2D6—urine—kidney cancer	0.00111	0.106	CbGeAlD
Praziquantel—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000979	0.0935	CbGeAlD
Praziquantel—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000838	0.08	CbGeAlD
Praziquantel—Arrhythmia—Gemcitabine—kidney cancer	0.000456	0.00329	CcSEcCtD
Praziquantel—Headache—Temsirolimus—kidney cancer	0.000456	0.00329	CcSEcCtD
Praziquantel—Decreased appetite—Erlotinib—kidney cancer	0.000454	0.00327	CcSEcCtD
Praziquantel—Dizziness—Pazopanib—kidney cancer	0.000453	0.00327	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000451	0.00325	CcSEcCtD
Praziquantel—Fatigue—Erlotinib—kidney cancer	0.00045	0.00324	CcSEcCtD
Praziquantel—Anorexia—Sorafenib—kidney cancer	0.000448	0.00323	CcSEcCtD
Praziquantel—Feeling abnormal—Vinblastine—kidney cancer	0.000448	0.00323	CcSEcCtD
Praziquantel—Myalgia—Dactinomycin—kidney cancer	0.000446	0.00322	CcSEcCtD
Praziquantel—Feeling abnormal—Everolimus—kidney cancer	0.000446	0.00321	CcSEcCtD
Praziquantel—Gastrointestinal pain—Vinblastine—kidney cancer	0.000444	0.0032	CcSEcCtD
Praziquantel—Nervous system disorder—Sunitinib—kidney cancer	0.000443	0.0032	CcSEcCtD
Praziquantel—Gastrointestinal pain—Everolimus—kidney cancer	0.000443	0.00319	CcSEcCtD
Praziquantel—Discomfort—Dactinomycin—kidney cancer	0.000441	0.00318	CcSEcCtD
Praziquantel—Skin disorder—Sunitinib—kidney cancer	0.000439	0.00316	CcSEcCtD
Praziquantel—Vomiting—Pazopanib—kidney cancer	0.000436	0.00314	CcSEcCtD
Praziquantel—Bradycardia—Paclitaxel—kidney cancer	0.000435	0.00314	CcSEcCtD
Praziquantel—Rash—Pazopanib—kidney cancer	0.000432	0.00311	CcSEcCtD
Praziquantel—Nausea—Temsirolimus—kidney cancer	0.000432	0.00311	CcSEcCtD
Praziquantel—Dermatitis—Pazopanib—kidney cancer	0.000432	0.00311	CcSEcCtD
Praziquantel—Anorexia—Sunitinib—kidney cancer	0.000431	0.00311	CcSEcCtD
Praziquantel—Abdominal pain—Vinblastine—kidney cancer	0.00043	0.0031	CcSEcCtD
Praziquantel—Headache—Pazopanib—kidney cancer	0.000429	0.00309	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000428	0.00308	CcSEcCtD
Praziquantel—Body temperature increased—Everolimus—kidney cancer	0.000428	0.00308	CcSEcCtD
Praziquantel—Abdominal pain—Everolimus—kidney cancer	0.000428	0.00308	CcSEcCtD
Praziquantel—Gastrointestinal pain—Erlotinib—kidney cancer	0.000427	0.00308	CcSEcCtD
Praziquantel—Vertigo—Vincristine—kidney cancer	0.000421	0.00303	CcSEcCtD
Praziquantel—Abdominal discomfort—Capecitabine—kidney cancer	0.00042	0.00303	CcSEcCtD
Praziquantel—Body temperature increased—Erlotinib—kidney cancer	0.000413	0.00298	CcSEcCtD
Praziquantel—Abdominal pain—Erlotinib—kidney cancer	0.000413	0.00298	CcSEcCtD
Praziquantel—Ill-defined disorder—Gemcitabine—kidney cancer	0.000412	0.00297	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000412	0.00297	CcSEcCtD
Praziquantel—Decreased appetite—Sorafenib—kidney cancer	0.000408	0.00294	CcSEcCtD
Praziquantel—Anorexia—Dactinomycin—kidney cancer	0.000408	0.00294	CcSEcCtD
Praziquantel—Nausea—Pazopanib—kidney cancer	0.000407	0.00293	CcSEcCtD
Praziquantel—Convulsion—Vincristine—kidney cancer	0.000406	0.00293	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000406	0.00292	CcSEcCtD
Praziquantel—CYP3A5—nephron tubule—kidney cancer	0.000405	0.0387	CbGeAlD
Praziquantel—Fatigue—Sorafenib—kidney cancer	0.000405	0.00292	CcSEcCtD
Praziquantel—Malaise—Gemcitabine—kidney cancer	0.000401	0.00289	CcSEcCtD
Praziquantel—Hypersensitivity—Vinblastine—kidney cancer	0.0004	0.00289	CcSEcCtD
Praziquantel—Myalgia—Vincristine—kidney cancer	0.000399	0.00287	CcSEcCtD
Praziquantel—Hypersensitivity—Everolimus—kidney cancer	0.000399	0.00287	CcSEcCtD
Praziquantel—Cardiac disorder—Paclitaxel—kidney cancer	0.000397	0.00286	CcSEcCtD
Praziquantel—Decreased appetite—Sunitinib—kidney cancer	0.000393	0.00283	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00039	0.00281	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00039	0.00281	CcSEcCtD
Praziquantel—Asthenia—Vinblastine—kidney cancer	0.00039	0.00281	CcSEcCtD
Praziquantel—Fatigue—Sunitinib—kidney cancer	0.00039	0.00281	CcSEcCtD
Praziquantel—Asthenia—Everolimus—kidney cancer	0.000388	0.0028	CcSEcCtD
Praziquantel—Immune system disorder—Paclitaxel—kidney cancer	0.000386	0.00278	CcSEcCtD
Praziquantel—Gastrointestinal pain—Sorafenib—kidney cancer	0.000384	0.00277	CcSEcCtD
Praziquantel—Pruritus—Everolimus—kidney cancer	0.000383	0.00276	CcSEcCtD
Praziquantel—CYP1A2—renal system—kidney cancer	0.000382	0.0365	CbGeAlD
Praziquantel—Arrhythmia—Paclitaxel—kidney cancer	0.000382	0.00275	CcSEcCtD
Praziquantel—Myalgia—Gemcitabine—kidney cancer	0.000378	0.00273	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000376	0.00271	CcSEcCtD
Praziquantel—Nervous system disorder—Vincristine—kidney cancer	0.000375	0.0027	CcSEcCtD
Praziquantel—Asthenia—Erlotinib—kidney cancer	0.000375	0.0027	CcSEcCtD
Praziquantel—Discomfort—Gemcitabine—kidney cancer	0.000374	0.00269	CcSEcCtD
Praziquantel—Urticaria—Sorafenib—kidney cancer	0.000373	0.00269	CcSEcCtD
Praziquantel—Decreased appetite—Dactinomycin—kidney cancer	0.000372	0.00268	CcSEcCtD
Praziquantel—Diarrhoea—Vinblastine—kidney cancer	0.000372	0.00268	CcSEcCtD
Praziquantel—Body temperature increased—Sorafenib—kidney cancer	0.000371	0.00268	CcSEcCtD
Praziquantel—Abdominal pain—Sorafenib—kidney cancer	0.000371	0.00268	CcSEcCtD
Praziquantel—Diarrhoea—Everolimus—kidney cancer	0.00037	0.00267	CcSEcCtD
Praziquantel—Gastrointestinal pain—Sunitinib—kidney cancer	0.00037	0.00266	CcSEcCtD
Praziquantel—Pruritus—Erlotinib—kidney cancer	0.00037	0.00266	CcSEcCtD
Praziquantel—Fatigue—Dactinomycin—kidney cancer	0.000369	0.00266	CcSEcCtD
Praziquantel—CYP3A5—renal system—kidney cancer	0.000369	0.0352	CbGeAlD
Praziquantel—Anorexia—Vincristine—kidney cancer	0.000365	0.00263	CcSEcCtD
Praziquantel—Dizziness—Vinblastine—kidney cancer	0.000359	0.00259	CcSEcCtD
Praziquantel—Dizziness—Everolimus—kidney cancer	0.000358	0.00258	CcSEcCtD
Praziquantel—Abdominal pain—Sunitinib—kidney cancer	0.000357	0.00258	CcSEcCtD
Praziquantel—Body temperature increased—Sunitinib—kidney cancer	0.000357	0.00258	CcSEcCtD
Praziquantel—Diarrhoea—Erlotinib—kidney cancer	0.000357	0.00258	CcSEcCtD
Praziquantel—Bradycardia—Capecitabine—kidney cancer	0.000357	0.00257	CcSEcCtD
Praziquantel—CYP3A5—kidney—kidney cancer	0.000356	0.034	CbGeAlD
Praziquantel—Nervous system disorder—Gemcitabine—kidney cancer	0.000356	0.00256	CcSEcCtD
Praziquantel—Feeling abnormal—Dactinomycin—kidney cancer	0.000353	0.00254	CcSEcCtD
Praziquantel—Skin disorder—Gemcitabine—kidney cancer	0.000352	0.00254	CcSEcCtD
Praziquantel—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00035	0.00252	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000348	0.00251	CcSEcCtD
Praziquantel—CYP3A5—cortex of kidney—kidney cancer	0.000347	0.0331	CbGeAlD
Praziquantel—Hypersensitivity—Sorafenib—kidney cancer	0.000346	0.00249	CcSEcCtD
Praziquantel—Anorexia—Gemcitabine—kidney cancer	0.000346	0.00249	CcSEcCtD
Praziquantel—Vomiting—Vinblastine—kidney cancer	0.000345	0.00249	CcSEcCtD
Praziquantel—Dizziness—Erlotinib—kidney cancer	0.000345	0.00249	CcSEcCtD
Praziquantel—Ill-defined disorder—Paclitaxel—kidney cancer	0.000345	0.00249	CcSEcCtD
Praziquantel—Vomiting—Everolimus—kidney cancer	0.000344	0.00248	CcSEcCtD
Praziquantel—Rash—Everolimus—kidney cancer	0.000341	0.00246	CcSEcCtD
Praziquantel—Dermatitis—Everolimus—kidney cancer	0.000341	0.00246	CcSEcCtD
Praziquantel—Headache—Vinblastine—kidney cancer	0.00034	0.00245	CcSEcCtD
Praziquantel—Headache—Everolimus—kidney cancer	0.000339	0.00244	CcSEcCtD
Praziquantel—Abdominal pain—Dactinomycin—kidney cancer	0.000338	0.00244	CcSEcCtD
Praziquantel—Body temperature increased—Dactinomycin—kidney cancer	0.000338	0.00244	CcSEcCtD
Praziquantel—Asthenia—Sorafenib—kidney cancer	0.000337	0.00243	CcSEcCtD
Praziquantel—Malaise—Paclitaxel—kidney cancer	0.000336	0.00242	CcSEcCtD
Praziquantel—Vertigo—Paclitaxel—kidney cancer	0.000334	0.00241	CcSEcCtD
Praziquantel—Hypersensitivity—Sunitinib—kidney cancer	0.000333	0.0024	CcSEcCtD
Praziquantel—Decreased appetite—Vincristine—kidney cancer	0.000332	0.0024	CcSEcCtD
Praziquantel—Pruritus—Sorafenib—kidney cancer	0.000332	0.0024	CcSEcCtD
Praziquantel—Vomiting—Erlotinib—kidney cancer	0.000332	0.00239	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000331	0.00238	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Vincristine—kidney cancer	0.00033	0.00238	CcSEcCtD
Praziquantel—Fatigue—Vincristine—kidney cancer	0.00033	0.00238	CcSEcCtD
Praziquantel—Rash—Erlotinib—kidney cancer	0.000329	0.00237	CcSEcCtD
Praziquantel—Dermatitis—Erlotinib—kidney cancer	0.000329	0.00237	CcSEcCtD
Praziquantel—Headache—Erlotinib—kidney cancer	0.000327	0.00236	CcSEcCtD
Praziquantel—Cardiac disorder—Capecitabine—kidney cancer	0.000326	0.00235	CcSEcCtD
Praziquantel—Asthenia—Sunitinib—kidney cancer	0.000324	0.00234	CcSEcCtD
Praziquantel—Nausea—Vinblastine—kidney cancer	0.000323	0.00233	CcSEcCtD
Praziquantel—Somnolence—Gemcitabine—kidney cancer	0.000323	0.00232	CcSEcCtD
Praziquantel—Convulsion—Paclitaxel—kidney cancer	0.000322	0.00232	CcSEcCtD
Praziquantel—Nausea—Everolimus—kidney cancer	0.000322	0.00232	CcSEcCtD
Praziquantel—Diarrhoea—Sorafenib—kidney cancer	0.000321	0.00232	CcSEcCtD
Praziquantel—Pruritus—Sunitinib—kidney cancer	0.00032	0.00231	CcSEcCtD
Praziquantel—Immune system disorder—Capecitabine—kidney cancer	0.000317	0.00228	CcSEcCtD
Praziquantel—Myalgia—Paclitaxel—kidney cancer	0.000317	0.00228	CcSEcCtD
Praziquantel—Decreased appetite—Gemcitabine—kidney cancer	0.000315	0.00227	CcSEcCtD
Praziquantel—Hypersensitivity—Dactinomycin—kidney cancer	0.000315	0.00227	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000315	0.00227	CcSEcCtD
Praziquantel—Arrhythmia—Capecitabine—kidney cancer	0.000313	0.00226	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000313	0.00226	CcSEcCtD
Praziquantel—Discomfort—Paclitaxel—kidney cancer	0.000313	0.00226	CcSEcCtD
Praziquantel—Fatigue—Gemcitabine—kidney cancer	0.000313	0.00225	CcSEcCtD
Praziquantel—Gastrointestinal pain—Vincristine—kidney cancer	0.000313	0.00225	CcSEcCtD
Praziquantel—Dizziness—Sorafenib—kidney cancer	0.000311	0.00224	CcSEcCtD
Praziquantel—Nausea—Erlotinib—kidney cancer	0.00031	0.00224	CcSEcCtD
Praziquantel—Diarrhoea—Sunitinib—kidney cancer	0.000309	0.00223	CcSEcCtD
Praziquantel—Asthenia—Dactinomycin—kidney cancer	0.000307	0.00221	CcSEcCtD
Praziquantel—Body temperature increased—Vincristine—kidney cancer	0.000302	0.00218	CcSEcCtD
Praziquantel—Abdominal pain—Vincristine—kidney cancer	0.000302	0.00218	CcSEcCtD
Praziquantel—Dizziness—Sunitinib—kidney cancer	0.000299	0.00215	CcSEcCtD
Praziquantel—Feeling abnormal—Gemcitabine—kidney cancer	0.000299	0.00215	CcSEcCtD
Praziquantel—Vomiting—Sorafenib—kidney cancer	0.000299	0.00215	CcSEcCtD
Praziquantel—Nervous system disorder—Paclitaxel—kidney cancer	0.000298	0.00215	CcSEcCtD
Praziquantel—Rash—Sorafenib—kidney cancer	0.000296	0.00213	CcSEcCtD
Praziquantel—Dermatitis—Sorafenib—kidney cancer	0.000296	0.00213	CcSEcCtD
Praziquantel—Skin disorder—Paclitaxel—kidney cancer	0.000295	0.00213	CcSEcCtD
Praziquantel—Headache—Sorafenib—kidney cancer	0.000294	0.00212	CcSEcCtD
Praziquantel—Diarrhoea—Dactinomycin—kidney cancer	0.000293	0.00211	CcSEcCtD
Praziquantel—Anorexia—Paclitaxel—kidney cancer	0.00029	0.00209	CcSEcCtD
Praziquantel—Vomiting—Sunitinib—kidney cancer	0.000287	0.00207	CcSEcCtD
Praziquantel—Body temperature increased—Gemcitabine—kidney cancer	0.000287	0.00207	CcSEcCtD
Praziquantel—Rash—Sunitinib—kidney cancer	0.000285	0.00205	CcSEcCtD
Praziquantel—Dermatitis—Sunitinib—kidney cancer	0.000285	0.00205	CcSEcCtD
Praziquantel—Ill-defined disorder—Capecitabine—kidney cancer	0.000283	0.00204	CcSEcCtD
Praziquantel—Headache—Sunitinib—kidney cancer	0.000283	0.00204	CcSEcCtD
Praziquantel—Hypersensitivity—Vincristine—kidney cancer	0.000282	0.00203	CcSEcCtD
Praziquantel—Eosinophilia—Doxorubicin—kidney cancer	0.00028	0.00202	CcSEcCtD
Praziquantel—Nausea—Sorafenib—kidney cancer	0.000279	0.00201	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000277	0.00199	CcSEcCtD
Praziquantel—CYP3A4—renal system—kidney cancer	0.000277	0.0264	CbGeAlD
Praziquantel—Malaise—Capecitabine—kidney cancer	0.000275	0.00198	CcSEcCtD
Praziquantel—Vertigo—Capecitabine—kidney cancer	0.000274	0.00198	CcSEcCtD
Praziquantel—Asthenia—Vincristine—kidney cancer	0.000274	0.00198	CcSEcCtD
Praziquantel—CYP2D6—renal system—kidney cancer	0.000272	0.026	CbGeAlD
Praziquantel—Vomiting—Dactinomycin—kidney cancer	0.000272	0.00196	CcSEcCtD
Praziquantel—Somnolence—Paclitaxel—kidney cancer	0.00027	0.00195	CcSEcCtD
Praziquantel—Rash—Dactinomycin—kidney cancer	0.00027	0.00194	CcSEcCtD
Praziquantel—Nausea—Sunitinib—kidney cancer	0.000269	0.00194	CcSEcCtD
Praziquantel—CYP3A4—kidney—kidney cancer	0.000267	0.0255	CbGeAlD
Praziquantel—Decreased appetite—Paclitaxel—kidney cancer	0.000264	0.0019	CcSEcCtD
Praziquantel—CYP2D6—kidney—kidney cancer	0.000263	0.0251	CbGeAlD
Praziquantel—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000262	0.00189	CcSEcCtD
Praziquantel—Fatigue—Paclitaxel—kidney cancer	0.000262	0.00189	CcSEcCtD
Praziquantel—Diarrhoea—Vincristine—kidney cancer	0.000262	0.00189	CcSEcCtD
Praziquantel—Asthenia—Gemcitabine—kidney cancer	0.00026	0.00188	CcSEcCtD
Praziquantel—Myalgia—Capecitabine—kidney cancer	0.00026	0.00187	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000258	0.00186	CcSEcCtD
Praziquantel—Discomfort—Capecitabine—kidney cancer	0.000257	0.00185	CcSEcCtD
Praziquantel—Pruritus—Gemcitabine—kidney cancer	0.000257	0.00185	CcSEcCtD
Praziquantel—Nausea—Dactinomycin—kidney cancer	0.000254	0.00183	CcSEcCtD
Praziquantel—Dizziness—Vincristine—kidney cancer	0.000253	0.00182	CcSEcCtD
Praziquantel—Drowsiness—Doxorubicin—kidney cancer	0.000252	0.00182	CcSEcCtD
Praziquantel—Feeling abnormal—Paclitaxel—kidney cancer	0.00025	0.0018	CcSEcCtD
Praziquantel—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000248	0.00179	CcSEcCtD
Praziquantel—Diarrhoea—Gemcitabine—kidney cancer	0.000248	0.00179	CcSEcCtD
Praziquantel—Nervous system disorder—Capecitabine—kidney cancer	0.000244	0.00176	CcSEcCtD
Praziquantel—Vomiting—Vincristine—kidney cancer	0.000243	0.00175	CcSEcCtD
Praziquantel—Skin disorder—Capecitabine—kidney cancer	0.000242	0.00174	CcSEcCtD
Praziquantel—Urticaria—Paclitaxel—kidney cancer	0.000241	0.00174	CcSEcCtD
Praziquantel—Rash—Vincristine—kidney cancer	0.000241	0.00174	CcSEcCtD
Praziquantel—Dermatitis—Vincristine—kidney cancer	0.000241	0.00174	CcSEcCtD
Praziquantel—Body temperature increased—Paclitaxel—kidney cancer	0.00024	0.00173	CcSEcCtD
Praziquantel—Abdominal pain—Paclitaxel—kidney cancer	0.00024	0.00173	CcSEcCtD
Praziquantel—Headache—Vincristine—kidney cancer	0.00024	0.00173	CcSEcCtD
Praziquantel—Anorexia—Capecitabine—kidney cancer	0.000238	0.00171	CcSEcCtD
Praziquantel—Vomiting—Gemcitabine—kidney cancer	0.000231	0.00166	CcSEcCtD
Praziquantel—Bradycardia—Doxorubicin—kidney cancer	0.00023	0.00166	CcSEcCtD
Praziquantel—Rash—Gemcitabine—kidney cancer	0.000229	0.00165	CcSEcCtD
Praziquantel—Dermatitis—Gemcitabine—kidney cancer	0.000229	0.00165	CcSEcCtD
Praziquantel—Headache—Gemcitabine—kidney cancer	0.000227	0.00164	CcSEcCtD
Praziquantel—Nausea—Vincristine—kidney cancer	0.000227	0.00164	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000227	0.00164	CcSEcCtD
Praziquantel—Hypersensitivity—Paclitaxel—kidney cancer	0.000224	0.00161	CcSEcCtD
Praziquantel—Asthenia—Paclitaxel—kidney cancer	0.000218	0.00157	CcSEcCtD
Praziquantel—Decreased appetite—Capecitabine—kidney cancer	0.000217	0.00156	CcSEcCtD
Praziquantel—Nausea—Gemcitabine—kidney cancer	0.000215	0.00155	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000215	0.00155	CcSEcCtD
Praziquantel—Fatigue—Capecitabine—kidney cancer	0.000215	0.00155	CcSEcCtD
Praziquantel—Pruritus—Paclitaxel—kidney cancer	0.000215	0.00155	CcSEcCtD
Praziquantel—Cardiac disorder—Doxorubicin—kidney cancer	0.00021	0.00151	CcSEcCtD
Praziquantel—Diarrhoea—Paclitaxel—kidney cancer	0.000208	0.0015	CcSEcCtD
Praziquantel—Feeling abnormal—Capecitabine—kidney cancer	0.000205	0.00148	CcSEcCtD
Praziquantel—Immune system disorder—Doxorubicin—kidney cancer	0.000204	0.00147	CcSEcCtD
Praziquantel—Gastrointestinal pain—Capecitabine—kidney cancer	0.000204	0.00147	CcSEcCtD
Praziquantel—Arrhythmia—Doxorubicin—kidney cancer	0.000202	0.00146	CcSEcCtD
Praziquantel—Dizziness—Paclitaxel—kidney cancer	0.000201	0.00145	CcSEcCtD
Praziquantel—Urticaria—Capecitabine—kidney cancer	0.000198	0.00143	CcSEcCtD
Praziquantel—Body temperature increased—Capecitabine—kidney cancer	0.000197	0.00142	CcSEcCtD
Praziquantel—Abdominal pain—Capecitabine—kidney cancer	0.000197	0.00142	CcSEcCtD
Praziquantel—Vomiting—Paclitaxel—kidney cancer	0.000193	0.00139	CcSEcCtD
Praziquantel—Rash—Paclitaxel—kidney cancer	0.000192	0.00138	CcSEcCtD
Praziquantel—Dermatitis—Paclitaxel—kidney cancer	0.000191	0.00138	CcSEcCtD
Praziquantel—Headache—Paclitaxel—kidney cancer	0.00019	0.00137	CcSEcCtD
Praziquantel—Hypersensitivity—Capecitabine—kidney cancer	0.000184	0.00132	CcSEcCtD
Praziquantel—Ill-defined disorder—Doxorubicin—kidney cancer	0.000183	0.00132	CcSEcCtD
Praziquantel—Nausea—Paclitaxel—kidney cancer	0.00018	0.0013	CcSEcCtD
Praziquantel—Asthenia—Capecitabine—kidney cancer	0.000179	0.00129	CcSEcCtD
Praziquantel—Malaise—Doxorubicin—kidney cancer	0.000178	0.00128	CcSEcCtD
Praziquantel—Vertigo—Doxorubicin—kidney cancer	0.000177	0.00127	CcSEcCtD
Praziquantel—Pruritus—Capecitabine—kidney cancer	0.000176	0.00127	CcSEcCtD
Praziquantel—Convulsion—Doxorubicin—kidney cancer	0.000171	0.00123	CcSEcCtD
Praziquantel—Diarrhoea—Capecitabine—kidney cancer	0.000171	0.00123	CcSEcCtD
Praziquantel—Myalgia—Doxorubicin—kidney cancer	0.000168	0.00121	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000166	0.0012	CcSEcCtD
Praziquantel—Discomfort—Doxorubicin—kidney cancer	0.000166	0.00119	CcSEcCtD
Praziquantel—Dizziness—Capecitabine—kidney cancer	0.000165	0.00119	CcSEcCtD
Praziquantel—Vomiting—Capecitabine—kidney cancer	0.000158	0.00114	CcSEcCtD
Praziquantel—Nervous system disorder—Doxorubicin—kidney cancer	0.000158	0.00114	CcSEcCtD
Praziquantel—Rash—Capecitabine—kidney cancer	0.000157	0.00113	CcSEcCtD
Praziquantel—Dermatitis—Capecitabine—kidney cancer	0.000157	0.00113	CcSEcCtD
Praziquantel—Headache—Capecitabine—kidney cancer	0.000156	0.00113	CcSEcCtD
Praziquantel—Skin disorder—Doxorubicin—kidney cancer	0.000156	0.00112	CcSEcCtD
Praziquantel—Anorexia—Doxorubicin—kidney cancer	0.000153	0.0011	CcSEcCtD
Praziquantel—Nausea—Capecitabine—kidney cancer	0.000148	0.00107	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000146	0.00105	CcSEcCtD
Praziquantel—Somnolence—Doxorubicin—kidney cancer	0.000143	0.00103	CcSEcCtD
Praziquantel—Decreased appetite—Doxorubicin—kidney cancer	0.00014	0.00101	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000139	0.001	CcSEcCtD
Praziquantel—Fatigue—Doxorubicin—kidney cancer	0.000139	0.000998	CcSEcCtD
Praziquantel—Feeling abnormal—Doxorubicin—kidney cancer	0.000132	0.000954	CcSEcCtD
Praziquantel—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000131	0.000947	CcSEcCtD
Praziquantel—Urticaria—Doxorubicin—kidney cancer	0.000128	0.00092	CcSEcCtD
Praziquantel—Abdominal pain—Doxorubicin—kidney cancer	0.000127	0.000915	CcSEcCtD
Praziquantel—Body temperature increased—Doxorubicin—kidney cancer	0.000127	0.000915	CcSEcCtD
Praziquantel—Hypersensitivity—Doxorubicin—kidney cancer	0.000118	0.000853	CcSEcCtD
Praziquantel—Asthenia—Doxorubicin—kidney cancer	0.000115	0.000831	CcSEcCtD
Praziquantel—Pruritus—Doxorubicin—kidney cancer	0.000114	0.000819	CcSEcCtD
Praziquantel—Diarrhoea—Doxorubicin—kidney cancer	0.00011	0.000792	CcSEcCtD
Praziquantel—Dizziness—Doxorubicin—kidney cancer	0.000106	0.000766	CcSEcCtD
Praziquantel—Vomiting—Doxorubicin—kidney cancer	0.000102	0.000736	CcSEcCtD
Praziquantel—Rash—Doxorubicin—kidney cancer	0.000101	0.00073	CcSEcCtD
Praziquantel—Dermatitis—Doxorubicin—kidney cancer	0.000101	0.000729	CcSEcCtD
Praziquantel—Headache—Doxorubicin—kidney cancer	0.000101	0.000725	CcSEcCtD
Praziquantel—Nausea—Doxorubicin—kidney cancer	9.54e-05	0.000688	CcSEcCtD
Praziquantel—CYP2D6—Biological oxidations—GSTM1—kidney cancer	3.21e-05	0.000953	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PDHB—kidney cancer	3.2e-05	0.00095	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	3.19e-05	0.000947	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—POMC—kidney cancer	3.19e-05	0.000947	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	3.16e-05	0.00094	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GPC3—kidney cancer	3.15e-05	0.000937	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	3.12e-05	0.000927	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.08e-05	0.000917	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CA2—kidney cancer	3.07e-05	0.000911	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	3.04e-05	0.000903	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CCBL1—kidney cancer	3.01e-05	0.000893	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	3e-05	0.000891	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ALAD—kidney cancer	2.99e-05	0.000888	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—GSTP1—kidney cancer	2.96e-05	0.000878	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	2.95e-05	0.000875	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ST3GAL2—kidney cancer	2.92e-05	0.000867	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	2.92e-05	0.000866	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ACY1—kidney cancer	2.91e-05	0.000864	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—GSTP1—kidney cancer	2.88e-05	0.000857	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ALDH1A1—kidney cancer	2.85e-05	0.000847	CbGpPWpGaD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.79e-05	0.000829	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—SLC5A3—kidney cancer	2.73e-05	0.000812	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PGK1—kidney cancer	2.73e-05	0.000812	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—ABCB1—kidney cancer	2.73e-05	0.000811	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—GSTM1—kidney cancer	2.72e-05	0.000807	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—LDHB—kidney cancer	2.68e-05	0.000796	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	2.68e-05	0.000796	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ACY1—kidney cancer	2.67e-05	0.000795	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—GSTM1—kidney cancer	2.65e-05	0.000787	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GLIPR1—kidney cancer	2.61e-05	0.000775	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PPAT—kidney cancer	2.61e-05	0.000775	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.58e-05	0.000765	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.54e-05	0.000755	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CYP1A1—kidney cancer	2.51e-05	0.000746	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.48e-05	0.000737	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PDHB—kidney cancer	2.47e-05	0.000735	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—POMC—kidney cancer	2.46e-05	0.000732	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—APRT—kidney cancer	2.42e-05	0.00072	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—FH—kidney cancer	2.42e-05	0.00072	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CCBL1—kidney cancer	2.32e-05	0.000691	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CA9—kidney cancer	2.32e-05	0.00069	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.28e-05	0.000678	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GPC3—kidney cancer	2.28e-05	0.000677	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PDHB—kidney cancer	2.27e-05	0.000676	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—POMC—kidney cancer	2.27e-05	0.000674	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ACY1—kidney cancer	2.27e-05	0.000673	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.25e-05	0.000669	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CA2—kidney cancer	2.22e-05	0.000659	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ALAD—kidney cancer	2.16e-05	0.000642	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CCBL1—kidney cancer	2.14e-05	0.000635	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ST3GAL2—kidney cancer	2.11e-05	0.000626	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.1e-05	0.000625	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.1e-05	0.000623	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.07e-05	0.000614	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ALDH1A1—kidney cancer	2.06e-05	0.000612	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.02e-05	0.000599	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PPAT—kidney cancer	2.02e-05	0.000599	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.99e-05	0.000591	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.99e-05	0.000591	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CRABP1—kidney cancer	1.98e-05	0.000587	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PGK1—kidney cancer	1.98e-05	0.000587	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.98e-05	0.000587	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.97e-05	0.000585	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.96e-05	0.000583	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—LDHB—kidney cancer	1.94e-05	0.000576	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.93e-05	0.000574	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PDHB—kidney cancer	1.93e-05	0.000572	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—POMC—kidney cancer	1.92e-05	0.000571	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—FH—kidney cancer	1.87e-05	0.000557	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—APRT—kidney cancer	1.87e-05	0.000557	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—POMC—kidney cancer	1.87e-05	0.000556	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.85e-05	0.000551	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PPAT—kidney cancer	1.85e-05	0.000551	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ITPR2—kidney cancer	1.84e-05	0.000546	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.83e-05	0.000544	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CCBL1—kidney cancer	1.81e-05	0.000538	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GPC3—kidney cancer	1.76e-05	0.000523	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ACY1—kidney cancer	1.75e-05	0.00052	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—FH—kidney cancer	1.72e-05	0.000512	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—APRT—kidney cancer	1.72e-05	0.000512	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CA2—kidney cancer	1.71e-05	0.000509	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CA9—kidney cancer	1.68e-05	0.000499	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GSTT1—kidney cancer	1.68e-05	0.000498	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ACHE—kidney cancer	1.68e-05	0.000498	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ALAD—kidney cancer	1.67e-05	0.000496	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.64e-05	0.000487	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.63e-05	0.000484	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GPC3—kidney cancer	1.62e-05	0.000481	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.59e-05	0.000473	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—SCARB1—kidney cancer	1.59e-05	0.000471	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CA2—kidney cancer	1.58e-05	0.000468	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.57e-05	0.000467	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PPAT—kidney cancer	1.57e-05	0.000467	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PTGS1—kidney cancer	1.57e-05	0.000466	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.55e-05	0.000461	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PSMD7—kidney cancer	1.54e-05	0.000457	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ALAD—kidney cancer	1.54e-05	0.000456	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.53e-05	0.000456	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PGK1—kidney cancer	1.53e-05	0.000454	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.53e-05	0.000454	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.5e-05	0.000445	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—LDHB—kidney cancer	1.5e-05	0.000445	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PTGS2—kidney cancer	1.49e-05	0.000444	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PDHB—kidney cancer	1.49e-05	0.000442	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—POMC—kidney cancer	1.48e-05	0.00044	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.47e-05	0.000435	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—APRT—kidney cancer	1.46e-05	0.000434	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—FH—kidney cancer	1.46e-05	0.000434	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—BCHE—kidney cancer	1.46e-05	0.000434	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.44e-05	0.000428	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CRABP1—kidney cancer	1.43e-05	0.000424	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.43e-05	0.000424	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PGK1—kidney cancer	1.4e-05	0.000417	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.4e-05	0.000417	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CCBL1—kidney cancer	1.4e-05	0.000415	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.39e-05	0.000414	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—LDHB—kidney cancer	1.38e-05	0.000409	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GPC3—kidney cancer	1.37e-05	0.000408	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CA2—kidney cancer	1.34e-05	0.000397	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ITPR2—kidney cancer	1.33e-05	0.000395	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PTEN—kidney cancer	1.3e-05	0.000387	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALAD—kidney cancer	1.3e-05	0.000387	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CA9—kidney cancer	1.3e-05	0.000386	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.27e-05	0.000377	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.27e-05	0.000377	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.24e-05	0.000369	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.21e-05	0.00036	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PPAT—kidney cancer	1.21e-05	0.00036	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTT1—kidney cancer	1.21e-05	0.00036	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ACHE—kidney cancer	1.21e-05	0.00036	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CA9—kidney cancer	1.19e-05	0.000355	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PGK1—kidney cancer	1.19e-05	0.000354	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.19e-05	0.000354	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—LDHB—kidney cancer	1.17e-05	0.000347	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GSTP1—kidney cancer	1.16e-05	0.000345	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—SCARB1—kidney cancer	1.15e-05	0.000341	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PTGS1—kidney cancer	1.13e-05	0.000337	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—FH—kidney cancer	1.13e-05	0.000335	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—APRT—kidney cancer	1.13e-05	0.000335	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PSMD7—kidney cancer	1.11e-05	0.000331	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CRABP1—kidney cancer	1.1e-05	0.000328	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ABCB1—kidney cancer	1.1e-05	0.000327	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GSTM1—kidney cancer	1.07e-05	0.000317	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GPC3—kidney cancer	1.06e-05	0.000315	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—BCHE—kidney cancer	1.05e-05	0.000313	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—SLC5A5—kidney cancer	1.04e-05	0.00031	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CA2—kidney cancer	1.03e-05	0.000306	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ITPR2—kidney cancer	1.03e-05	0.000305	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CRABP1—kidney cancer	1.02e-05	0.000302	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CA9—kidney cancer	1.01e-05	0.000301	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP1A1—kidney cancer	1.01e-05	0.000301	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—SLC2A1—kidney cancer	1.01e-05	0.000299	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALAD—kidney cancer	1e-05	0.000298	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.89e-06	0.000294	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ST3GAL2—kidney cancer	9.8e-06	0.000291	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ALDH1A1—kidney cancer	9.58e-06	0.000285	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.46e-06	0.000281	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ITPR2—kidney cancer	9.44e-06	0.000281	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTT1—kidney cancer	9.36e-06	0.000278	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ACHE—kidney cancer	9.36e-06	0.000278	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PIK3CA—kidney cancer	9.19e-06	0.000273	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PGK1—kidney cancer	9.18e-06	0.000273	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SLC5A3—kidney cancer	9.18e-06	0.000273	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—LDHB—kidney cancer	9.01e-06	0.000268	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SCARB1—kidney cancer	8.86e-06	0.000263	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PTGS1—kidney cancer	8.77e-06	0.000261	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ACHE—kidney cancer	8.61e-06	0.000256	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTT1—kidney cancer	8.61e-06	0.000256	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CRABP1—kidney cancer	8.6e-06	0.000256	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PSMD7—kidney cancer	8.6e-06	0.000256	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTP1—kidney cancer	8.39e-06	0.000249	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—BCHE—kidney cancer	8.15e-06	0.000242	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SCARB1—kidney cancer	8.15e-06	0.000242	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PTGS1—kidney cancer	8.07e-06	0.00024	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SLC5A5—kidney cancer	8.06e-06	0.000239	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ITPR2—kidney cancer	8e-06	0.000238	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ABCB1—kidney cancer	7.94e-06	0.000236	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PSMD7—kidney cancer	7.91e-06	0.000235	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CA9—kidney cancer	7.81e-06	0.000232	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—SLC2A1—kidney cancer	7.78e-06	0.000231	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GSTM1—kidney cancer	7.71e-06	0.000229	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.55e-06	0.000224	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—POMC—kidney cancer	7.54e-06	0.000224	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—BCHE—kidney cancer	7.5e-06	0.000223	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SLC5A5—kidney cancer	7.41e-06	0.00022	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.37e-06	0.000219	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP1A1—kidney cancer	7.31e-06	0.000217	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ACHE—kidney cancer	7.29e-06	0.000217	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTT1—kidney cancer	7.29e-06	0.000217	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—SLC2A1—kidney cancer	7.16e-06	0.000213	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SCARB1—kidney cancer	6.9e-06	0.000205	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PTGS1—kidney cancer	6.83e-06	0.000203	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PSMD7—kidney cancer	6.7e-06	0.000199	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CRABP1—kidney cancer	6.64e-06	0.000197	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.58e-06	0.000196	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTP1—kidney cancer	6.49e-06	0.000193	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—BCHE—kidney cancer	6.35e-06	0.000189	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SLC5A5—kidney cancer	6.28e-06	0.000187	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ITPR2—kidney cancer	6.17e-06	0.000183	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ABCB1—kidney cancer	6.14e-06	0.000183	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—SLC2A1—kidney cancer	6.06e-06	0.00018	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PTGS2—kidney cancer	6.02e-06	0.000179	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTP1—kidney cancer	5.97e-06	0.000177	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GSTM1—kidney cancer	5.96e-06	0.000177	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.88e-06	0.000175	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.65e-06	0.000168	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ABCB1—kidney cancer	5.65e-06	0.000168	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ACHE—kidney cancer	5.63e-06	0.000167	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTT1—kidney cancer	5.63e-06	0.000167	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GSTM1—kidney cancer	5.48e-06	0.000163	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—POMC—kidney cancer	5.45e-06	0.000162	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SCARB1—kidney cancer	5.33e-06	0.000158	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PTGS1—kidney cancer	5.27e-06	0.000157	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PTEN—kidney cancer	5.25e-06	0.000156	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP1A1—kidney cancer	5.2e-06	0.000154	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PSMD7—kidney cancer	5.17e-06	0.000154	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.13e-06	0.000152	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTP1—kidney cancer	5.06e-06	0.00015	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—BCHE—kidney cancer	4.9e-06	0.000146	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.84e-06	0.000144	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ABCB1—kidney cancer	4.79e-06	0.000142	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.68e-06	0.000139	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GSTM1—kidney cancer	4.65e-06	0.000138	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.64e-06	0.000138	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.4e-06	0.000131	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PTGS2—kidney cancer	4.35e-06	0.000129	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—POMC—kidney cancer	4.21e-06	0.000125	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTP1—kidney cancer	3.9e-06	0.000116	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—POMC—kidney cancer	3.88e-06	0.000115	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PTEN—kidney cancer	3.79e-06	0.000113	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PIK3CA—kidney cancer	3.7e-06	0.00011	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ABCB1—kidney cancer	3.69e-06	0.00011	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.62e-06	0.000108	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GSTM1—kidney cancer	3.59e-06	0.000107	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.4e-06	0.000101	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PTGS2—kidney cancer	3.36e-06	9.99e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—POMC—kidney cancer	3.28e-06	9.76e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PTGS2—kidney cancer	3.09e-06	9.19e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PTEN—kidney cancer	2.93e-06	8.71e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PTEN—kidney cancer	2.7e-06	8.01e-05	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.68e-06	7.95e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PTGS2—kidney cancer	2.62e-06	7.78e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—POMC—kidney cancer	2.53e-06	7.53e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PTEN—kidney cancer	2.28e-06	6.79e-05	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.07e-06	6.15e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PTGS2—kidney cancer	2.02e-06	6.01e-05	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.9e-06	5.65e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PTEN—kidney cancer	1.76e-06	5.24e-05	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.61e-06	4.79e-05	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.24e-06	3.7e-05	CbGpPWpGaD
